Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 3, Issue 16
August 27 2019
Issue Cover

Table of Contents

EXCEPTIONAL CASE REPORTS

Normal peripheral blood neutrophil numbers accompanying ELANE whole gene deletion mutation
Clinical Trials & Observations
Marshall S. Horwitz,Mercy Y. Laurino,Siobán B. Keel
View Articletitled, Normal peripheral blood neutrophil numbers accompanying <em>ELANE</em> whole gene deletion mutation
Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies
Clinical Trials & Observations
Adam D. Cohen,Alfred L. Garfall,Ahmet Dogan,Simon F. Lacey,Chris Martin,Nikoletta Lendvai,Dan T. Vogl,Matthew Spear,Alexander M. Lesokhin
View Articletitled, Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies

STIMULUS REPORTS

Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia
Hyun Don Yun,Dawn K. Schirm,Martin Felices,Jeffrey S. Miller,Craig E. Eckfeldt
View Articletitled, Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia
The association of CMV with NK-cell reconstitution depends on graft source: results from BMT CTN-0201 samples
Clinical Trials & Observations
Armin Rashidi,Xianghua Luo,Sarah Cooley,Claudio Anasetti,Edmund K. Waller,Claudio G. Brunstein,Frank Cichocki,Daniel J. Weisdorf,Jeffrey S. Miller
View Articletitled, The association of CMV with NK-cell reconstitution depends on graft source: results from BMT CTN-0201 samples
Supplemental data
Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis
Elina K. Cook,Terumi Izukawa,Sherylan Young,Gili Rosen,Mina Jamali,Liying Zhang,Dylan Johnson,Eva Bain,Jamie Hilland,Christina K. Ferrone,Jonah Buckstein,Janika Francis,Bushra Momtaz,Amy J. M. McNaughton,Xudong Liu,Brooke Snetsinger,Rena Buckstein,Michael J. Rauh
View Articletitled, Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis
Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

Long-term outcome of patients with relapsed/refractory B-cell non-Hodgkin lymphoma treated with blinatumomab
Clinical Trials & Observations
Vera Dufner,Cyrus M. Sayehli,Manik Chatterjee,Horst D. Hummel,Götz Gelbrich,Ralf C. Bargou,Maria-Elisabeth Goebeler
View Articletitled, Long-term outcome of patients with relapsed/refractory B-cell non-Hodgkin lymphoma treated with blinatumomab
Supplemental data

LYMPHOID NEOPLASIA

Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials
Clinical Trials & Observations
Tomasz K. Wojdacz,Harindra E. Amarasinghe,Latha Kadalayil,Alice Beattie,Jade Forster,Stuart J. Blakemore,Helen Parker,Dean Bryant,Marta Larrayoz,Ruth Clifford,Pauline Robbe,Zadie A. Davis,Monica Else,Dena R. Howard,Basile Stamatopoulos,Andrew J. Steele,Richard Rosenquist,Andrew Collins,Andrew R. Pettitt,Peter Hillmen,Christoph Plass,Anna Schuh,Daniel Catovsky,David G. Oscier,Matthew J. J. Rose-Zerilli,Christopher C. Oakes,Jonathan C. Strefford
View Articletitled, Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Zfp281 (ZBP-99) plays a functionally redundant role with Zfp148 (ZBP-89) during erythroid development
Andrew J. Woo,Chelsea-Ann A. Patry,Alireza Ghamari,Gabriela Pregernig,Daniel Yuan,Kangni Zheng,Taylor Piers,Moira Hibbs,Ji Li,Miguel Fidalgo,Jenny Y. Wang,Joo-Hyeon Lee,Peter J. Leedman,Jianlong Wang,Ernest Fraenkel,Alan B. Cantor
View Articletitled, Zfp281 (ZBP-99) plays a functionally redundant role with Zfp148 (ZBP-89) during erythroid development
Supplemental data

THROMBOSIS AND HEMOSTASIS

Monocyte procoagulant responses to anthrax peptidoglycan are reinforced by proinflammatory cytokine signaling
Narcis Ioan Popescu,Alanson Girton,Tarea Burgett,Kessa Lovelady,K. Mark Coggeshall
View Articletitled, Monocyte procoagulant responses to anthrax peptidoglycan are reinforced by proinflammatory cytokine signaling
Supplemental data

TRANSPLANTATION

Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort
Clinical Trials & Observations
Michael A. Spinner,Vanessa E. Kennedy,John S. Tamaresis,Philip W. Lavori,Sally Arai,Laura J. Johnston,Everett H. Meyer,David B. Miklos,Lori S. Muffly,Robert S. Negrin,Andrew R. Rezvani,Judith A. Shizuru,Wen-Kai Weng,Richard T. Hoppe,Samuel Strober,Robert Lowsky
View Articletitled, Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort
Supplemental data
Multiple functional variants in the IL1RL1 region are pretransplant markers for risk of GVHD and infection deaths
Ezgi Karaesmen,Theresa Hahn,Alexander James Dile,Abbas A. Rizvi,Junke Wang,Tao Wang,Michael D. Haagenson,Leah Preus,Qianqian Zhu,Qian Liu,Li Yan,Song Liu,Christopher A. Haiman,Daniel Stram,Loreall Pooler,Xin Sheng,David Van Den Berg,Guy Brock,Amy Webb,Philip L. McCarthy,Marcelo C. Pasquini,Stephen R. Spellman,Stephanie J. Lee,Sophie Paczesny,Lara E. Sucheston-Campbell
View Articletitled, Multiple functional variants in the <em>IL1RL1</em> region are pretransplant markers for risk of GVHD and infection deaths
Supplemental data

ERRATUM

Abraham AA, John TD, Keller MD, et al. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Adv. 2019;3(14):2057-2068.
View Articletitled, Abraham AA, John TD, Keller MD, et al. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. <em>Blood Adv.</em> 2019;3(14):2057-2068.
  • Cover Image

    Cover Image

    issue cover

    COVER FIGURE
    Schematic diagram illustrating the effects of the experimental drug dinaciclib on acute myeloid leukemia and highlighting its ability to sensitize leukemic cells to natural killer cell cytotoxicity. See the article by Yun et al.

  • PDF Icon PDF LinkFront Matter
  • PDF Icon PDF LinkEditorial Board
All Issues

Advertisement intended for health care professionals

Time to revisit reduced-dose radiotherapy for PCNSL?
Lin A, Brown S, Chinapen S, et al. Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant. Blood Adv. 2023;7(23):7153-7160.
Jalink M, Jacobs CF, Khwaja J, et al. Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease. Blood Adv. 2024;8(11):2622-2634.
Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes
Retreatment of multiple myeloma with previously refractory drugs

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals